Ian Clements serves as Executive at Mirum Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Ian Clements has executed 15 insider transactions totaling $172.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 10, 2022 involved receiving (via award) 325 shares valued at $5.5K.
Ian Clements currently holds 30,011 shares of Mirum Pharmaceuticals, Inc. (MIRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ian Clements has been a net buyer of MIRM stock. They have purchased $142.2K and sold $30.3K worth of shares.
Ian Clements's most recent insider trade was on Nov 10, 2022, when they sold 325 shares at $17.05 per share.
Get notified when new Form 4 filings are submitted
| $13.57 |
| Discretionary |
| Jan 6, 2022 | MIRM | $0 | Award | 10,000 | $N/A | Discretionary |
| Nov 26, 2021 | MIRM | $10.4K | Purchase | 750 | $13.90 | Discretionary |
| Nov 24, 2021 | MIRM | $10.1K | Purchase | 700 | $14.40 | Discretionary |
| Nov 10, 2021 | MIRM | $6.2K | Award | 458 | $13.52 | Discretionary |
| Oct 1, 2021 | MIRM | $30.3K | Sale | 1,574 | $19.26 | Discretionary |
| Sep 29, 2021 | MIRM | $0 | Award | 9,375 | $N/A | Discretionary |
| May 10, 2021 | MIRM | $14.3K | Award | 981 | $14.62 | Discretionary |
| Dec 23, 2020 | MIRM | $29.7K | Purchase | 1,592 | $18.65 | Discretionary |
| Dec 23, 2020 | MIRM | $29.1K | Purchase | 1,562 | $18.65 | Discretionary |
| Dec 23, 2020 | MIRM | $16.8K | Purchase | 908 | $18.55 | Discretionary |
| Nov 10, 2020 | MIRM | $20.9K | Award | 1,371 | $15.27 | Discretionary |
| Sep 6, 2019 | MIRM | $19.9K | Purchase | 1,801 | $11.07 | Discretionary |
| Sep 6, 2019 | MIRM | $26.1K | Purchase | 2,199 | $11.87 | Discretionary |